dental implants
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The subject voluntarily participates in the trial and signs on Informed Consent Form; 2. The patient of which the age is 18 to 75 years old; 3. The patient who suffers from dentition damage or loss and needs dental implant therapy; 4. The edentulousalveolar cavity healed well, or more than three months passed after tooth extraction; 5. Theedentulous area has sufficient bone height and width for implant placement; 6. The implant area has healthy attached gingiva with sufficient thickness and width; 7. The oral mucosa or soft tissue has no significant inflammation or lesion; 8. The patient can communicate well with the researcher and can follow the entire verification requirements.
Exclusion criteria
Exclusion criteria: 1. Malocclusion or bad mastication habit affected the edentulousperiphery, which may lead to an implantation failure caused by the injury of bone tissue around the implant; the partial alveolar bone has any pathologic change; the oral mucosa has any lesion; the edentulous area has severe soft tissue lesion or severe periodontal disease; mouth opening is restricted; the bone mass and density in the edentulous area are unsatisfactory and difficult to improve; 2. The patient suffers acute infection or serious infection; 3. The patient is a pregnant woman or a breast-feeding woman; 4. The patient has long-term administration of special medicines such as hormones, anticoagulant drugs, etc.; 5. The patient has a poor condition of body health or nutrition; 6. The patient who suffers hematological disease and cardiovascular disease that are not controlled (coronary heart disease, congenital heart disease, etc.); 7. Systemic or localized bone disease is considered the contradiction of implant rehabilitation, such as bone tuberculosis, osteitis, bone tumor, etc.; 8. The patient who suffers systemic immune disease; 9. The patient who suffers nervous system disease, such as epileptic; 10. The patient who suffers mental disease or psychological barrier; 11. The patient who suffers endocrinal and metabolic disease that is not controlled; 12. The patient who has a history of head and neck radiotherapy or received chemotherapy within recent five years; 13. The patient who is allergic to metals; 14. Other cases in which the patient is unsuitable to participate in the research in the opinion of researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implant success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| the side effect that may occur after the patient is implanted with this dental implant system, to record in each visit the damage and looseness of the implant and its abutment, bone loss around the implant, fracture or infection of the implant, etc.;; | — |
Countries
China
Contacts
Shanghai East Hospital